Mapi Research Trust selected by Sanofi to develop their Patient-Reported Outcome (PRO) questionnaires website

USA - English

• USA - English

LYON, France, Nov. 2, 2017 /PRNewswire/ -- Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs), has partnered with Sanofi to develop the Sanofi PRO questionnaires website showcasing all PRO questionnaires developed or currently in development by Sanofi across various therapeutic areas and diseases.

"For more than 20 years, Sanofi has explored how diseases and medications impact patients' daily life by developing over 15 PRO questionnaires in various therapeutic areas e.g. cardiovascular diseases, urogenital diseases, nutritional & metabolic diseases or digestive system diseases and implementing them in their clinical programs," said Aude Roborel de Climens, COA Lead at Sanofi.

Sanofi developed and validated their PRO questionnaires according to the most rigorous scientific standards and selected Mapi Research Trust, the most trusted name in the distribution of COA instruments representing over 320 exclusive questionnaires, and Mapi Language Services, part of ICON plc and a  leader in linguistic validation, to be the exclusive licensor, distributor and translator of all Sanofi's PRO questionnaires and derivatives, including translations and electronic versions. "Our new Sanofi PRO questionnaires website developed with Mapi Research Trust will significantly increase the visibility and circulation of Sanofi questionnaires including those currently in development," she added.

"Helping Sanofi highlight their continuous efforts in capturing patient perspective during drug development, and facilitating the access to Sanofi's PRO questionnaires by the scientific community, is part of Mapi Research Trust's global mission," said Katrin Conway, Managing Director of the Mapi Research Trust. "The new Sanofi PRO website provides detailed information on each questionnaire; its objective, targeted population, content and structure, development and validation, review copy and available translations, with a link to Mapi Research Trust's online ePROVIDE platform when there is a need for more information by users or for requesting access to the questionnaires."

To view the new Sanofi PRO questionnaires website, please consult https://patient-questionnaires.sanofi.com/

About Mapi Research Trust:
Mapi Research Trust is a Non-Profit arm of Mapi Group (an ICON plc company) and works in collaboration with Academic Researchers, Life-Science Companies and Regulatory bodies. It is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 320 exclusive questionnaires.

Visit http://mapi-trust.org/ for more information.

About Mapi Language Services:
Mapi Language Services, part of ICON's Commercialisation & Outcomes group, is the worldwide leader in medical translation and Linguistic Validation of COAs for nearly three decades. Mapi has first-hand knowledge of local languages and cultures, regulations, and healthcare practices. We work in close collaboration with developers, assure conceptual equivalence and international harmonization of all language versions. Mapi Language Services' experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages.

Press contact: [email protected]

SOURCE Mapi Research Trust

Related Links

http://www.mapigroup.com